Shares of Philip Morris International Inc. (NYSE: PM) stayed green on Thursday after the company reported second quarter 2023 earnings results that surpassed projections. The stock has gained 3% over the past one month. Here’s a look at the key points from the earnings report:
Better-than-expected results
Philip Morris’ Q2 2023 revenue increased 14.5% year-over-year to $9 billion, beating estimates of $8.6 billion. Adjusted EPS grew 17% to $1.60, exceeding expectations of $1.47.
Organic revenues grew 10.5% in the quarter, driven by a 3% growth in cigarette and HTU shipment volume, favorable product mix associated with more smoke-free products in the portfolio, and pricing.
Business performance
In Q2, IQOS continued to perform well, driven mainly by IQOS ILUMA, which makes up about two-thirds of the IQOS business by volume. As stated on PMI’s quarterly conference call, there were an estimated 27.2 million IQOS users as of June 30, reflecting a growth of 1.4 million adult users in the second quarter. In Europe, IQOS users are nearing 12 million, with the further roll-out of ILUMA, which is available to about 70% of users in the region.
Another growth driver is ZYN nicotine pouches, which grew volumes in the US by over 50% during Q2. This growth was driven by increases in distribution and a rise in store velocities. These two products are playing a meaningful role in driving Philip Morris’ smoke-free transformation.
During Q2, HTU shipment volumes totaled 31.4 billion units, reflecting a growth of 26.6% YoY, fueled by strong performance in Europe and Japan. Cigarette volumes declined 0.4% in the quarter.
Revised outlook
PMI increased its full-year 2023 guidance for organic revenue growth to 7.5-8.5% based on strength in IQOS and ZYN and the resilience of its combustible business. It also revised its outlook for adjusted EPS to a range of $6.13-6.22 from the previous range of $6.10-6.22.
For the third quarter of 2023, the company expects high single-digit organic top line growth. Adjusted EPS is expected to be $1.60-1.65.
Most Popular
STZ Earnings Preview: Can Constellation Brands leverage growing beer sales?
Constellation Brands, Inc. (NYSE: STZ) has effectively navigated challenges like cautious consumer spending and declining demand for its wine and spirits brands by capitalizing on the sustained growth in the
What to look for when Lamb Weston (LW) reports its Q3 2025 earnings results
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) stayed green on Friday. The stock has dropped 19% over the past three months. The French fry giant is slated to report
Walgreens Boots Alliance set to report Q2 earnings. Here’s what to expect
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in health and wellness services, is preparing to report second-quarter results, with market watchers forecasting a mixed outcome. As part of
